EDQM: New Guideline for sterile Substances published for Comment
Recommendation
19/20 March 2025
Barcelona, Spain
Applying for and maintaining marketing authorisations: What you need to know from a GMP perspective
Register now for ECA's GMP Newsletter
The draft of the new guideline "Content of the dossier for sterile substances" (PA/PH/CEP (23) 54, draft 4) is now available for comments on the EDQM (European Directorate for the Quality of Medicines & HealthCare) website. Remarks and comments can be submitted until 15 August 2024.
The guideline consists of three chapters, with chapter 3 containing further subsections. The document is organised as follows:
1. Introduction
2. Scope
3. Documentation to be provided for the sterile substance
- Justification for method of sterilisation Manufacturing areas
- Summary of manufacturing process related to sterile filtration/aseptic processing
- Information on filters used
- Validation of the filters used
- Sterilisation of filters and processing equipment
- Pre-filtration Bioburden
- Re-use of filters
- Aseptic processing
- Process Simulation / Validation
- Sterilisation of Packaging
- Re-test Period
On the EDQM website go to the section "Consultation space" to find and comment on the draft of the Guideline "Content of the dossier for sterile substances" (PA/PH/CEP (23) 54, draft 4).
Related GMP News
11.03.2025EMA: Renewal of Q&A Document for "Centralized Procedures"
11.03.2025Centralised Procedures: Q&A Documents also Updated for Biosimilars
11.03.2025CMDh/HMA: Guidance Documents on Variation Notifications Updated
29.01.2025CMDh/HMA: Updated Guidance Documents on Variation Notifications
29.01.2025EMA: Q&A Documents for "Centralized Procedures" revised
28.01.2025ANVISA recognises CEPs